These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22593556)

  • 1. Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra.
    Langeslay DJ; Young RP; Beni S; Beecher CN; Mueller LJ; Larive CK
    Glycobiology; 2012 Sep; 22(9):1173-82. PubMed ID: 22593556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the 1H and 15N NMR resonances of sulfamate groups in aqueous solution: a new tool for heparin and heparan sulfate characterization.
    Langeslay DJ; Beni S; Larive CK
    Anal Chem; 2011 Oct; 83(20):8006-10. PubMed ID: 21913677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyl-proton hydrogen bonding in the heparin oligosaccharide Arixtra in aqueous solution.
    Beecher CN; Young RP; Langeslay DJ; Mueller LJ; Larive CK
    J Phys Chem B; 2014 Jan; 118(2):482-91. PubMed ID: 24354321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A closer look at the nitrogen next door: 1H-15N NMR methods for glycosaminoglycan structural characterization.
    Langeslay DJ; Beni S; Larive CK
    J Magn Reson; 2012 Mar; 216():169-74. PubMed ID: 22364674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active conformations of glycosaminoglycans. NMR determination of the conformation of heparin sequences complexed with antithrombin and fibroblast growth factors in solution.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Naggi A; Casu B
    Semin Thromb Hemost; 2002 Aug; 28(4):325-34. PubMed ID: 12244479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
    Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
    Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the microstructure of heparin and heparan sulfate using N-sulfoglucosamine 1H and 15N NMR chemical shift analysis.
    Langeslay DJ; Beecher CN; Naggi A; Guerrini M; Torri G; Larive CK
    Anal Chem; 2013 Jan; 85(2):1247-55. PubMed ID: 23240897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational selection of the AGA*IA(M) heparin pentasaccharide when bound to the fibroblast growth factor receptor.
    Nieto L; Canales Á; Giménez-Gallego G; Nieto PM; Jiménez-Barbero J
    Chemistry; 2011 Sep; 17(40):11204-9. PubMed ID: 21922554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural studies of octasaccharides derived from the low-sulfated repeating disaccharide region and octasaccharide serines derived from the protein linkage region of porcine intestinal heparin.
    Yamada S; Sakamoto K; Tsuda H; Yoshida K; Sugiura M; Sugahara K
    Biochemistry; 1999 Jan; 38(2):838-47. PubMed ID: 9888825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?
    Petitou M; van Boeckel CA
    Angew Chem Int Ed Engl; 2004 Jun; 43(24):3118-33. PubMed ID: 15199558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution Structure of Heparin Pentasaccharide: NMR and DFT Analysis.
    Hricovíni M
    J Phys Chem B; 2015 Sep; 119(38):12397-409. PubMed ID: 26340667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
    Richard B; Swanson R; Olson ST
    J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparin-like heparan sulfate from rabbit cartilage.
    Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
    Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Linkage region" sequences of heparins and heparan sulfates: detection and quantification by nuclear magnetic resonance spectroscopy.
    Iacomini M; Casu B; Guerrini M; Naggi A; Pirola A; Torri G
    Anal Biochem; 1999 Oct; 274(1):50-8. PubMed ID: 10527496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile.
    Petitou M; Nancy-Portebois V; Dubreucq G; Motte V; Meuleman D; de Kort M; van Boeckel CA; Vogel GM; Wisse JA
    Thromb Haemost; 2009 Nov; 102(5):804-10. PubMed ID: 19888512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended Physicochemical Characterization of the Synthetic Anticoagulant Pentasaccharide Fondaparinux Sodium by Quantitative NMR and Single Crystal X-ray Analysis.
    Wildt W; Kooijman H; Funke C; Üstün B; Leika A; Lunenburg M; Kaspersen F; Kellenbach E
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28817073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ¹H and (15)N NMR Analyses on Heparin, Heparan Sulfates and Related Monosaccharides Concerning the Chemical Exchange Regime of the N-Sulfo-Glucosamine Sulfamate Proton.
    Pomin VH
    Pharmaceuticals (Basel); 2016 Sep; 9(3):. PubMed ID: 27618066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformation of heparin pentasaccharide bound to antithrombin III.
    Hricovíni M; Guerrini M; Bisio A; Torri G; Petitou M; Casu B
    Biochem J; 2001 Oct; 359(Pt 2):265-72. PubMed ID: 11583572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energetics of hydrogen bond switch, residue burial and cavity analysis reveals molecular basis of improved heparin binding to antithrombin.
    Singh P; Singh K; Jairajpuri MA
    J Biomol Struct Dyn; 2011 Oct; 29(2):339-50. PubMed ID: 21875153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.